Innovations in Actinic Keratosis

被引：0

作者：

Lyle, Rawlings E. ^{[1
]}

Tran, Linh H. ^{[1
]}

Eisen, Daniel B. ^{[1
,2
]}

机构：

[1] Univ Calif Sacramento, Davis Sch Med, Dept Dermatol, 4610 X St, Sacramento, CA 95817 USA

[2] Univ Calif Davis, Dept Dermatol, Med Ctr, 3301 C St,Suite 1300, Sacramento, CA 95816 USA

来源：

DERMATOLOGIC CLINICS | 2025年 / 43卷 / 01期

关键词：

Actinic keratosis; Squamous cell carcinoma; UV radiation; Field cancerization; Photodynamic therapy; Dermatologic therapies; Photodamage; Immunosuppression; SQUAMOUS-CELL CARCINOMA; ABLATIVE FRACTIONAL LASER; PHOTODYNAMIC THERAPY; SKIN-CANCER; BLUE-LIGHT; CHEMOPREVENTION; PREVENTION; MANAGEMENT; EFFICACY; SAFETY;

D O I：

10.1016/j.det.2024.08.006

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

This literature review has addressed key areas in the management of AKs, focusing on therapeutic clinical trials, pathophysiological research, and the effectiveness of program implementation. The progress in PDT protocols, novel topical agents, and the application of advanced diagnostic tools and AI to enhance treatment precision has been outlined. Studies on the pathophysiology of AK have offered insights into its molecular basis, aiming to direct future therapeutic strategies. Additionally, investigations into program implementation have sought to improve diagnostic accuracy, treatment adherence, and patient-centric care.

引用

页码：77 / 94

页数：18

共 50 条

[31] Impact of interval and combination therapies on the management of actinic keratosis: Review and clinical considerations [J].

Martin, George M. .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2011, 22 (05) :288-297

[32] Adherence to topical therapies in actinic keratosis: A literature review [J].

Foley, Peter ;

Stockfleth, Eggert ;

Peris, Ketty ;

Basset-Seguin, Nicole ;

Cerio, Rino ;

Sanches, Jose Antonio ;

Guillen, Carlos ;

Farrington, Emily ;

Lebwohl, Mark .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (06) :538-545

[33] Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis [J].

Berman, Brian .

EXPERT OPINION ON DRUG SAFETY, 2015, 14 (12) :1969-1978

[34] Epidemiology of actinic keratosis [J].

Velter, C. .

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2019, 146 :S3-S9

[35] How to treat actinic keratosis? An update [J].

Costa, Claudia ;

Scalvenzi, Massimiliano ;

Ayala, Fabio ;

Fabbrocini, Gabriella ;

Monfrecola, Giuseppe .

JOURNAL OF DERMATOLOGICAL CASE REPORTS, 2015, 9 (02) :28-34

[36] Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice [J].

Skroza, Nevena ;

Bernardini, Nicoletta ;

Proietti, Ilaria ;

Potenza, Concetta .

THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 :1879-1885

[37] Advances in Photodynamic Therapy for the Treatment of Actinic Keratosis and Nonmelanoma Skin Cancer: A Narrative Review [J].

Aaron S. Farberg ;

Justin W. Marson ;

Teo Soleymani .

Dermatology and Therapy, 2023, 13 :689-716

[38] Levulan®:: the first approved topical photosensitizer for the treatment of actinic keratosis [J].

Jeffes, EWB .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2002, 13 (01) :S19-S23

[39] A Nationwide Cohort Study of Actinic Keratosis in Taiwan [J].

Hsieh, Chi-Feng ;

Chiang, Yi-Ting ;

Chiu, Hsien-Yi ;

Huang, Weng-Foung .

INTERNATIONAL JOURNAL OF GERONTOLOGY, 2016, 10 (04) :218-222

[40] Pathology and pathobiology of actinic (solar) keratosis - an update [J].

Roewert-Huber, J. ;

Stockfleth, E. ;

Kerl, H. .

BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 :18-20

← 1 2 3 4 5 →